143 related articles for article (PubMed ID: 38488347)
1. Androgen Receptor Immunohistochemistry is Superior to PRAME for the Differentiation of Sebaceous Carcinoma From Primary Cutaneous Basaloid Mimics.
Wakefield C; Russell-Goldman E
Am J Dermatopathol; 2024 Apr; 46(4):195-203. PubMed ID: 38488347
[TBL] [Abstract][Full Text] [Related]
2. HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases.
Hamza MA; Quick CM; Williams HR; Patil NM; Shalin SC
Int J Gynecol Pathol; 2023 Jul; 42(4):338-346. PubMed ID: 36383010
[TBL] [Abstract][Full Text] [Related]
3. Sebaceous lesions of the skin.
Iacobelli J; Harvey NT; Wood BA
Pathology; 2017 Dec; 49(7):688-697. PubMed ID: 29078997
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation.
Bayer-Garner IB; Givens V; Smoller B
Am J Dermatopathol; 1999 Oct; 21(5):426-31. PubMed ID: 10535570
[TBL] [Abstract][Full Text] [Related]
6. PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures.
Ng JKM; Choi PCL; Chow C; Li JJX; Chan AWS; Cheung CMT; Ip ECC; Ng HK; To KF
Pathology; 2022 Oct; 54(6):721-728. PubMed ID: 35644638
[TBL] [Abstract][Full Text] [Related]
7. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
8. Sebaceoma and related neoplasms with sebaceous differentiation: a clinicopathologic study of 30 cases.
Misago N; Mihara I; Ansai S; Narisawa Y
Am J Dermatopathol; 2002 Aug; 24(4):294-304. PubMed ID: 12142607
[TBL] [Abstract][Full Text] [Related]
9. Periocular Sebaceous Carcinoma: A Case Audit from the National Specialist Ophthalmic Pathology Service in Liverpool from 2009 to 2022 to Assess the Diagnostic Utility of PRAME Expression.
Salleh AA; Krishna Y; Coupland SE
Ocul Oncol Pathol; 2024 Apr; 10(1):1-8. PubMed ID: 38645737
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 15 expression in neoplasms with sebaceous differentiation.
Misago N; Narisawa Y
J Cutan Pathol; 2006 Sep; 33(9):634-41. PubMed ID: 16965339
[TBL] [Abstract][Full Text] [Related]
11. Sebaceous Neoplasms.
Flux K
Surg Pathol Clin; 2017 Jun; 10(2):367-382. PubMed ID: 28477886
[TBL] [Abstract][Full Text] [Related]
12. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.
Shalin SC; Lyle S; Calonje E; Lazar AJ
Histopathology; 2010 Jan; 56(1):133-47. PubMed ID: 20055911
[TBL] [Abstract][Full Text] [Related]
13. Sebaceous Carcinoma in Situ Masquerading Clinically and Histologically as Paget Disease of the Breast.
Tjarks BJ; Kerkvliet AM; Jassim AD
S D Med; 2018 Aug; 71(8):350-353. PubMed ID: 30110525
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adipophilin and recently introduced PReferentially expressed Antigen in MElanoma immunohistochemistry in the assessment of sebaceous neoplasms: A pilot study.
Donnell SA; LeBlanc RE; Yan S; Parra O; Momtahen S; Sriharan A; Linos K
J Cutan Pathol; 2021 Oct; 48(10):1252-1261. PubMed ID: 33949693
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor expression in epidermal and adnexal tumours.
Bourlond F; Velter C; Cribier B
Ann Dermatol Venereol; 2021 Jun; 148(2):116-121. PubMed ID: 33478823
[TBL] [Abstract][Full Text] [Related]
17. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
18. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome.
Harrington CR; Egbert BM; Swetter SM
Dermatol Surg; 2004 May; 30(5):817-9. PubMed ID: 15099333
[TBL] [Abstract][Full Text] [Related]
19. Apocrine carcinoma with marked sebocyte-like cytological features: A report of two cases.
Sasaki-Saito N; Goto K; Aoki M; Nishihara K; Hiraki T; Yoshikawa S; Matsushita S
J Cutan Pathol; 2024 Feb; 51(2):92-98. PubMed ID: 37743579
[TBL] [Abstract][Full Text] [Related]
20. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
Rishi K; Font RL
Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
